학술논문
Safety and efficacy of tofacitinib up to 48 months in patients with active psoriatic arthritis: final analysis of the OPAL Balance long-term extension study
Document Type
Article
Author
Source
In The Lancet Rheumatology April 2021 3(4):e270-e283
Subject
Language
ISSN
2665-9913